Schroder Investment Management Group
CORT icon

Schroder Investment Management Group’s Corcept Therapeutics CORT Stock Holding History

Schroder Investment Management Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-96,914
Closed -$1.97M – 1267
2022
Q4 		$1.97M Sell
96,914
-12,036
-11% -$302K ﹤0.01% 945
2022
Q3 		$2.79M Sell
108,950
-52,572
-33% -$1.41M ﹤0.01% 884
2022
Q2 		$4M Buy
161,522
+30,588
+23% +$666K 0.01% 835
2022
Q1 		$3.17M Sell
130,934
-7,585
-5% -$161K ﹤0.01% 936
2021
Q4 		$2.74M Sell
138,519
-4,990
-3% -$101K ﹤0.01% 871
2021
Q3 		$2.82M Sell
143,509
-12,008
-8% -$251K ﹤0.01% 909
2021
Q2 		$3.42M Buy
155,517
+35,217
+29% +$784K ﹤0.01% 905
2021
Q1 		$2.86M Sell
120,300
-139,622
-54% -$3.73M ﹤0.01% 941
2020
Q4 		$6.8M Buy
259,922
+92,176
+55% +$1.94M 0.01% 733
2020
Q3 		$2.84M Sell
167,746
-9,133
-5% -$146K ﹤0.01% 834
2020
Q2 		$2.98M Sell
176,879
-28,348
-14% -$398K 0.01% 755
2020
Q1 		$2.37M Buy
205,227
+187,365
+1,049% +$2.32M 0.01% 775
2019
Q4 		$216K Buy
17,862
+1,409
+9% +$19.6K ﹤0.01% 1155
2019
Q3 		$240K Buy
+16,453
New +$202K ﹤0.01% 1137
2018
Q3 		– Sell
-29,680
Closed -$469K – 1288
2018
Q2 		$469K Buy
29,680
+527
+2% +$9.17K ﹤0.01% 1047
2018
Q1 		$480K Buy
29,153
+1,665
+6% +$30.9K ﹤0.01% 1063
2017
Q4 		$496K Buy
27,488
+4,688
+21% +$84.9K ﹤0.01% 1096
2017
Q3 		$432K Hold
22,800
– – ﹤0.01% 1097
2017
Q2 		$272K Buy
+22,800
New +$248K ﹤0.01% 1131

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group's CORT Position: Q1 2023 in Review

Schroder Investment Management Group sold out of Corcept Therapeutics (CORT) in Q1 2023, closing a stake of 96,914 shares — an estimated $1.97M sold.

Schroder Investment Management Group first reported a position in CORT in Q2 2017 and held it in 19 quarters. The position peaked at $6.8M in Q4 2020. 232 funds tracked by Wall St. Rank hold CORT as of Q1 2023.

  • Schroder Investment Management Group reported no remaining Corcept Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 96,914 Corcept Therapeutics shares in Q1 2023, an estimated $1.97M.
  • Schroder Investment Management Group first reported a position in Corcept Therapeutics in Q2 2017 and held it in 19 quarters.
  • Schroder Investment Management Group's Corcept Therapeutics position peaked at $6.8M in Q4 2020.
  • 232 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2023.

Based on Schroder Investment Management Group's 13F filing for Q1 2023, filed 11 May 2023.